Innovative VR and Behavioral Health Solution for Healing Trauma Prepares for Rapid Expansion
LAS VEGAS–(BUSINESS WIRE)–#healthcare–Veteran workers’ compensation executive Chris Watson is joining the Advisory Board for Harvard MedTech, a breakthrough digital health company that combines virtual reality, behavioral therapy, and artificial intelligence in a revolutionary new approach to healing trauma and pain.
“Harvard MedTech’s innovative solution is changing the approach to treating both acute and chronic pain associated with workplace injuries,” said Watson. “By providing a non-pharmacological alternative combining virtual reality therapy along with support by behavioral health experts, they are improving people’s quality of life by enhancing their ability to deal with pain, reducing opioid utilization, and accelerating return to work. Long-term claims and their costs are minimized and the risk of addiction to narcotics is reduced. This is the solution the workers’ compensation industry has been waiting for.”
“We are delighted to welcome Chris to our Advisory Board, as our company prepares for rapid growth and adoption in workers’ compensation,” said Shan Padda, Chief Executive Officer, Harvard MedTech. “As a well-respected and seasoned executive in workers’ compensation, Chris will be heavily involved in working with me and our senior team in setting the strategic direction for the firm.”
Watson was most recently Chief Operating Officer for One Call Care Management, a leading provider of specialized solutions to the workers’ compensation industry. Previously he had served as Chief Operating Officer at Coventry Workers’ Compensation Services. His previous positions also include COO at Auto Injury Solutions, President at First Script, VP of Operations at Concentra Network Services, and VP of Provider Relations at Em3.
He earned a Bachelor of Business Administration in Finance from Texas A&M University and proudly served in the U.S. Marine Corps as an F/A-18 pilot.
He joins a distinguished group of experts on the Harvard MedTech Advisory Board, including Chris Dimos, Chief Operating Officer at AccentCare and former President of the Retail Solutions team at McKesson Pharmaceutical Solutions and Services, and George Riedl, former President of Pharmacy, Health & Wellness for Walmart U.S., the world’s largest retailer.
For more information, visit www.Harvardmedtech.com.
About Harvard MedTech
Harvard MedTech is a breakthrough digital health company that is tapping the new science of how the brain works, combining specially designed virtual reality experiences, psychosocial support, digital engagement and proprietary AI algorithms to retrain neural pathways and alleviate the effects of trauma, including pain, PTSD, anxiety, depression and sleep disorders. The company’s Vx Therapy model is the first to comprehensively integrate this unique combination of digital technologies with behavioral health interventions, in a virtual application that moves the points of care to the patient’s home. This virtual engagement drives high compliance, patient satisfaction and optimal outcomes. It also allows the solution to be affordable and scalable at a population health level. This non-invasive and non-pharmacological approach also provides data that is trackable for a clear assess of its value to patient and health care providers. Visit www.harvardmedtech.com for more information.